Georgios Apostolopoulos Holdings made a tender offer to acquire 30% stake in Diagnostic and Therapeutic Center of Athens Hygeia SA (ATSE:HYGEIA) from Marfin Investment Group Holdings S.A. (ATSE:MIG) and others for €41.3 million on November 23, 2017. Under the tender offer, Georgios Apostolopoulos will acquire 91.7 million Diagnostic and Therapeutic Center of Athens Hygeia shares at a price of €0.45 per share in cash. As of November 24, 2017, Marfin Investment Group, Hygeia's main shareholder, rejected the offer. During its meeting on November 27, 2017, the Board of Directors of Hygeia decided to appoint an independent financial advisor to draw up a valuation report on the fair value of Hygeia's shares. The Board Members also announced that they are not willing to proceed with the sale of any shares. The information memorandum of the tender offer was approved by the Capital Market Commission on December 15, 2017. The acceptance period of the tender offer started from December 20, 2017 and will expire on January 17, 2018. Euroxx Securities S.A. (ATSE:EX) acted as financial advisor to Diagnostic and Therapeutic Center of Athens Hygeia SA.

Georgios Apostolopoulos Holdings cancelled the tender offer to acquire 30% stake in Diagnostic and Therapeutic Center of Athens Hygeia SA (ATSE:HYGEIA) from Marfin Investment Group Holdings S.A. (ATSE:MIG) and others on December 21, 2017. As on December 21, 2017, the Board of Directors of Diagnostic and Therapeutic Center of Athens Hygeia SA held a meeting and formulated its reasoned opinion with regard to the offer. The Board concluded that the offered consideration is not considered as fair and reasonable from a financial point of view as it is substantially lower than the lower limit of the fair and reasonable value range. Accordingly, Hygeia Board rejected the offer.